Results 111 to 120 of about 4,624 (147)

[The guidelines for diagnosis and treatment of myeloma bone disease in China (2022)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2022
Hematological Oncology Committee of China Anti-Cancer Association   +2 more
europepmc   +1 more source

[Multiple myeloma with chromothripsis: three cases report]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2022
Wu CX   +10 more
europepmc   +1 more source

[The role and molecular mechanism of transcription factor EB and its target genes in multiple myeloma treatment with bortezomib]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Zhang RJ   +8 more
europepmc   +1 more source

[Effects of extramedullary disease on patients with newly diagnosed multiple myeloma]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2023
Tao Y   +8 more
europepmc   +1 more source

A prognostic model for multiple myeloma based on lipid metabolism related genes. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban
Li Z, Zhao L, Shi F, Guo J, Zhou W.
europepmc   +1 more source

[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Sun CY   +30 more
europepmc   +1 more source

[Research progress in targeting GPRC5D for the treatment of multiple myeloma]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
An JY, Pan MM, Ouyang HY, Mi JQ.
europepmc   +1 more source

[Chinese expert consensus on standard procedures for the outpatient management of patients with multiple myeloma (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy